{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:37:40Z","timestamp":1761863860829,"version":"3.37.3"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Youth Natural Science Foundation of China","award":["81602400"],"award-info":[{"award-number":["81602400"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672002"],"award-info":[{"award-number":["81672002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Provincial Department of Health","award":["H201537"],"award-info":[{"award-number":["H201537"]}]},{"name":"Science and Technology Department of Jiangsu Province","award":["BK20161105"],"award-info":[{"award-number":["BK20161105"]}]},{"name":"Key Medical Center of Jiangsu Provincial Department of Health","award":["YXZXB2016004"],"award-info":[{"award-number":["YXZXB2016004"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.virusres.2018.07.021","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T12:26:36Z","timestamp":1533039996000},"page":"165-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comparison of replication competence of wild-type and lamivudine-resistant hepatitis B virus isolates from a chronic hepatitis B patient"],"prefix":"10.1016","volume":"255","author":[{"given":"Quan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjie","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2018.07.021_bib0005","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/hep.510270628","article-title":"Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group","volume":"7","author":"Allen","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.07.021_bib0010","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.22790","article-title":"The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains","volume":"49","author":"Amini-Bavil-Olyaee","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.07.021_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3449","article-title":"Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma","volume":"13","author":"Arzumanyan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.virusres.2018.07.021_bib0020","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/AAC.41.11.2484","article-title":"Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase","volume":"41","author":"Back","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2018.07.021_bib0025","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1002\/j.1460-2075.1996.tb00777.x","article-title":"Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme","volume":"15","author":"Back","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.virusres.2018.07.021_bib0030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1053\/gast.2002.31015","article-title":"Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation","volume":"122","author":"Bock","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virusres.2018.07.021_bib0035","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1517\/13543780903241599","article-title":"Monotherapy versus combination therapy for the treatment of chronic hepatitis B","volume":"18","author":"Carey","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.virusres.2018.07.021_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/jhep.2003.50012","article-title":"Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro","volume":"37","author":"Chen","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.07.021_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/095632020101200101","article-title":"Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation","volume":"12","author":"Delaney","year":"2001","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.virusres.2018.07.021_bib0050","doi-asserted-by":"crossref","first-page":"11833","DOI":"10.1128\/JVI.77.21.11833-11841.2003","article-title":"The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro","volume":"77","author":"Delaney","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.07.021_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11262-013-0915-1","article-title":"Dynamics of lamivudine-resistant hepatitis B virus strains in patients with entecavir rescue therapy","volume":"47","author":"Deng","year":"2013","journal-title":"Virus Genes"},{"key":"10.1016\/j.virusres.2018.07.021_bib0060","first-page":"31","article-title":"Viral mutant discovery in hepatitis B virus quasi-species in patients undergoing long-term lamivudine treatment","volume":"21","author":"Ding","year":"2015","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.virusres.2018.07.021_bib0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1440-1746.2008.05570.x","article-title":"Emergence of adefovir-resistant mutants after reversion to YMDD wild-type in lamivudine-resistant patients receiving adefovir monotherapy","volume":"24","author":"Kwon","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virusres.2018.07.021_bib0070","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1053\/jhep.2000.17912","article-title":"Long-term therapy of chronic hepatitis B with lamivudine","volume":"32","author":"Lau","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.07.021_bib0075","article-title":"Rare detection of occult hepatitis B virus infection in children of mothers with positive hepatitis B surface antigen","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.virusres.2018.07.021_bib0080","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/hep.510270243","article-title":"Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective","volume":"27","author":"Melegari","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.07.021_bib0085","doi-asserted-by":"crossref","first-page":"17047","DOI":"10.1038\/srep17047","article-title":"Hepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptide","volume":"5","author":"Okuyama-Dobashi","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virusres.2018.07.021_bib0090","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/hep.510290340","article-title":"YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: a study by in vitro full-length viral DNA transfection","volume":"29","author":"Ono-Nita","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.virusres.2018.07.021_bib0095","first-page":"91","volume":"126","author":"Peters","year":"2004","journal-title":"Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology"},{"key":"10.1016\/j.virusres.2018.07.021_bib0100","first-page":"307","volume":"45","author":"Rapti","year":"2007","journal-title":"Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B. Hepatology"},{"key":"10.1016\/j.virusres.2018.07.021_bib0105","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","article-title":"Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013","volume":"386","author":"Schweitzer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2018.07.021_bib0110","doi-asserted-by":"crossref","first-page":"334","DOI":"10.21037\/atm.2016.09.19","article-title":"Treatment for hepatitis B in patients with drug resistance","volume":"4","author":"Tacke","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.virusres.2018.07.021_bib0115","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.2174\/0929867043364333","article-title":"Influence of mutations in the hepatitis B virus genome on virus replication and drug resistance--implications for novel antiviral strategies","volume":"11","author":"Tacke","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.virusres.2018.07.021_bib0120","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jhep.2016.01.027","article-title":"Overview of hepatitis B viral replication and genetic variability","volume":"64","author":"Tong","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2018.07.021_bib0125","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3435965","article-title":"Antiviral therapy in lamivudine-resistant chronic hepatitis B patients: a systematic review and network meta-analysis","volume":"2016","author":"Wang","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.virusres.2018.07.021_bib0130","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"10.1016\/j.virusres.2018.07.021_bib0135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3350\/cmh.2014.20.3.267","article-title":"Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir","volume":"20","author":"Ze","year":"2014","journal-title":"Clin. Mol. Hepatol."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218303198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218303198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T15:45:25Z","timestamp":1569080725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170218303198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":27,"alternative-id":["S0168170218303198"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2018.07.021","relation":{},"ISSN":["0168-1702"],"issn-type":[{"type":"print","value":"0168-1702"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of replication competence of wild-type and lamivudine-resistant hepatitis B virus isolates from a chronic hepatitis B patient","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2018.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}